-+ 0.00%
-+ 0.00%
-+ 0.00%

COMPASS THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN AN INVESTIGATOR SPONSORED TRIAL OF TOVECIMIG IN THE FIRST-LINE SETTING FOR PATIENTS WITH BILIARY TRACT CANCER

Reuters·04/21/2025 12:00:00

Please log in to view news